197 related articles for article (PubMed ID: 25889931)
1. Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients.
Benvenuto M; Sileri P; Rossi P; Masuelli L; Fantini M; Nanni M; Franceschilli L; Sconocchia G; Lanzilli G; Arriga R; Faggioni G; Lista F; Orlandi A; Manzari V; Gaspari AL; Modesti A; Bei R
J Transl Med; 2015 Mar; 13():101. PubMed ID: 25889931
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice.
Marzocchella L; Sini V; Buonomo O; Orlandi A; Masuelli L; Bonanno E; Lista F; Turriziani M; Manzari V; Roselli M; Modesti A; Bei R
Cancer Sci; 2011 Mar; 102(3):509-15. PubMed ID: 21175994
[TBL] [Abstract][Full Text] [Related]
3. The ribosomal P0 protein induces a spontaneous immune response in patients with head and neck advanced stage carcinoma that is not dependent on its overexpression in carcinomas.
Bei R; Masuelli L; Trono P; Orvietani PL; Losito S; Marzocchella L; Vitolo D; Albonici L; Mrozek MA; Di Gennaro E; Lista F; Faggioni G; Ionna F; Binaglia L; Manzari V; Budillon A; Modesti A
Int J Oncol; 2007 Dec; 31(6):1301-8. PubMed ID: 17982655
[TBL] [Abstract][Full Text] [Related]
4. Local radiotherapy increases the level of autoantibodies to ribosomal P0 protein but not to heat shock proteins, extracellular matrix molecules and EGFR/ErbB2 receptors in prostate cancer patients.
Ingrosso G; Fantini M; Nardi A; Benvenuto M; Sacchetti P; Masuelli L; Ponti E; Frajese GV; Lista F; Schillaci O; Santoni R; Modesti A; Bei R
Oncol Rep; 2013 Mar; 29(3):1167-74. PubMed ID: 23254686
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins.
Fabien N; Moreira A; Lavergne JP; Desbos A; Surgey P; Alves de Olivera C; Gonzalo P; Venot A; Bienvenu J; Perrier H; Reboud JP; Monier JC
J Autoimmun; 1999 Aug; 13(1):103-10. PubMed ID: 10441174
[TBL] [Abstract][Full Text] [Related]
6. Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus.
Lin JL; Dubljevic V; Fritzler MJ; Toh BH
Clin Exp Immunol; 2005 Jul; 141(1):155-64. PubMed ID: 15958082
[TBL] [Abstract][Full Text] [Related]
7. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
8. Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.
Luo B; Yun X; Fan R; Lin YD; He SJ; Zhang QM; Mo FR; Chen F; Xiao SW; Xie XX
Int J Clin Exp Pathol; 2013; 6(12):2835-45. PubMed ID: 24294369
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal P protein P0 as a candidate for the target antigen of anti-endothelial cell antibodies in mixed connective tissue disease.
Naniwa T; Sugiura Y; Banno S; Yoshinouchi T; Matsumoto Y; Ueda R
Clin Exp Rheumatol; 2007; 25(4):593-8. PubMed ID: 17888216
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
[TBL] [Abstract][Full Text] [Related]
11. Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer.
Nagorsen D; Keilholz U; Rivoltini L; Schmittel A; Letsch A; Asemissen AM; Berger G; Buhr HJ; Thiel E; Scheibenbogen C
Cancer Res; 2000 Sep; 60(17):4850-4. PubMed ID: 10987297
[TBL] [Abstract][Full Text] [Related]
12. Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection.
Kessenbrock K; Fritzler MJ; Groves M; Eissfeller P; von Mühlen CA; Höpfl P; Mahler M
J Mol Med (Berl); 2007 Sep; 85(9):953-9. PubMed ID: 17668158
[TBL] [Abstract][Full Text] [Related]
13. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
[TBL] [Abstract][Full Text] [Related]
14. Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention.
Corulli LR; Cecil DL; Gad E; Koehnlein M; Coveler AL; Childs JS; Lubet RA; Disis ML
Front Immunol; 2021; 12():729809. PubMed ID: 34526999
[TBL] [Abstract][Full Text] [Related]
15. Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region.
Bruner BF; Wynn DM; Reichlin M; Harley JB; James JA
Ann N Y Acad Sci; 2005 Jun; 1051():390-403. PubMed ID: 16126981
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
[TBL] [Abstract][Full Text] [Related]
17. Antibody targeting of claudin-1 as a potential colorectal cancer therapy.
Cherradi S; Ayrolles-Torro A; Vezzo-Vié N; Gueguinou N; Denis V; Combes E; Boissière F; Busson M; Canterel-Thouennon L; Mollevi C; Pugnière M; Bibeau F; Ychou M; Martineau P; Gongora C; Del Rio M
J Exp Clin Cancer Res; 2017 Jun; 36(1):89. PubMed ID: 28659146
[TBL] [Abstract][Full Text] [Related]
18. Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.
Boxer GM; Abassi AM; Pedley RB; Begent RH
Br J Cancer; 1994 Feb; 69(2):307-14. PubMed ID: 7507692
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
Meenakshi A; Kumar NS; Vijayshanker SG
Hum Antibodies; 2000; 9(4):223-9. PubMed ID: 11341176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
